However, protein synthesis is unperturbed by targeting the AR-CaMKK2-AMPK pathway in prostate cancer cells, suggesting that although CaMKK2 stimulates glycolysis, it has no significant effects on biosynthesis [42]. Here, PRKAA1 is linked to Familial prostate cancer.